predicting outcome from dengue
TRANSCRIPT
Predicting outcome from dengue
Dr Sophie Yacoub
Imperial College LondonOxford University Clinical Research Unit, Vietnam
ESCMID eLibrary
by a
uthor
The global dengue burden
• Dengue most abundant arboviral infection
• Current estimates: 390 million infections (96 million clinically
apparent) 1
1. Bhatt S, et al. Global distribution of dengue. Nature 2013
ESCMID eLibrary
by a
uthor
The Virus
• Dengue caused by one of the 4 antigenically distinct dengue virus
serotypes (DENV1-4).
• Family Flaviviridae
• Single-stranded enveloped RNA virus, 30 nm in diameter.
• Transmitted from person to person by Aedes mosquitoes.
• The dengue virus genome encodes 3 structural proteins; Capsid (C)
Precursor membrane (prM) and Envelope (E), and 7 Non-structural
proteins:
C Pr/M E NS1 NS2a 2b NS3 NS4a 4b NS5
Structural Non-structural ESCMID eLibrary
by a
uthor
Dengue in Europe
• Reports of travellers acquiring dengue are increasing.
• Plus autochthonous cases presenting in non-endemic areas
where the mosquito vectors have become newly established
• Surveillance data shows dengue is now the most common cause
fever in travellers returning from all geographical regions except
Sub-Saharan Africa and Central America.ESCMID eLibrary
by a
uthor
Dengue in Vietnam
Hanoi Southern Vietnam
ESCMID eLibrary
by a
uthor
WHO, 2009
ESCMID eLibrary
by a
uthor
Critical
period
Capillary leakage
viraemia
0 1 2 3 4 5 6
days
Inflammatory
host response
Shock
Bleeding
Organ
impairment
Febrile phase Recovery phase
ESCMID eLibrary
by a
uthor
Potential complications
Capillary leak:
-Fluid accumulation-Shock
Bleeding:
-Skin/mucosal/GI etc
ESCMID eLibrary
by a
uthor
Organ involvement
Liver: Hepatitis, ALT>1000
Brain: Acute encephalitis syndrome without other manifestations
of the disease .
Heart: Acute myocarditis, conduction disturbances and myocardial
depression.
ESCMID eLibrary
by a
uthor
Treatment
• No specific antivirals or adjunctive therapies have shown benefit,
management relies on symptomatic and supportive treatment.
• Meticulous fluid balance and cautious intravenous fluid
• Minimum volume of parenteral fluid should be given - adequate
organ perfusion
ESCMID eLibrary
by a
uthor
Predicting outcome from dengue
• Clinical/laboratory parameters
• Viral markers
• Immunological parameters
• Novel biomarkers
• Microcirculation
• Endothelial activation markers
Simmons CP et al. N Engl J Med 2012;366:1423-1432.
ESCMID eLibrary
by a
uthor
Risk Factors for severe disease
• Most commonly secondary infections with a different serotype (ADE)
• Age influences clinical phenotype;
-severe plasma leakage more likely to occur in children
-major bleeding in adults
• Older age (>60 years) or young patients (<15 years),
• Pregnant women
• Patients with co-morbidities such as diabetes and uncontrolled
hypertension.
• Patients with over and under nutritionESCMID eLibrary
by a
uthor
Clinical assessment of severity
DF (n = 312) DHF (n = 319) P†
Days ill, no. (%)
≤3 104 (33) 52 (16) <0.01
>3 208 (67) 267 (84)
Vomiting, no. (%) 178 (57) 234 (73) <0.01
Abdominal pain, no. (%) 156 (50) 234/318 (74) <0.01
Headache, no. (%) 140/307 (46) 88/318 (28) <0.01
Reported bleeding, no. (%) 56 (18) 36 (11) 0.02
Spontaneous petechiae, no. (%) 230 (74) 292 (92) <0.01
Liver size, no. (%)
≤1 cm 256 (82) 145 (45) <0.01
>1 cm 56 (18) 174 (55)
Haematocrit, %, median (90% range)
40 (34–49) 48 (40–54) <0.01
Platelet count ≤100,000/mm3, no. (%)
195/296 (66) 294/311 (95) <0.01
Platelet count/mm3, median (90% range)
84,500 (43,000–160,000)
66,000 (40,000–110,000)
<0.01
Phuong CX et al. Am J Trop Med Hyg. 2004
ESCMID eLibrary
by a
uthor
Clinical assessment: plasma leakage
• Haemoconcentration:
(Change in haematocrit)
• Haemodynamic
monitoring
(pulse pressure)
• Albumin levels
ESCMID eLibrary
by a
uthor
Laboratory biomarkers- Platelets
Platelet counts in children and adults with shock (top) and uncomplicated dengue (bottom )
Trung DT, PLoS NTD, 2012
ESCMID eLibrary
by a
uthor
Clinical decision algorithm for predicting severe dengue
A. Decision algorithm for severity prediction
B. PLT = platelet count;Ct = viral load (high Ct-value indicates low viral load)IgG = positive result indicates a secondary infectionLow = platelet nadir of 50,000/mm3 or less; high = platelet nadir greater than 50,000/mm3
Tanner L et al. Plos NTD 2008
Sensitivity of 78.2% & specificity of 80.2%ESCMID eLibrary
by a
uthor
Other laboratory markers: Liver enzymes
Lee LK. et al 2012 Plos Negl Trop Dis
Trung DT. et al 2010 AJTMH
ESCMID eLibrary
by a
uthor
Microalbuminuria for predicting outcome
• Dengue patients generally had higher UACRs than the OFI patients • But microalbuminuria, using cutoff of 30 mg albumin/g creatinine discriminated
poorly between the two diagnostic groups. • UACRs did not prove useful in predicting either development of warning signs for
severe dengue or need for hospitalization.Hanh NT et al.Plos one 2013
ESCMID eLibrary
by a
uthor
Imaging studies:
Serial ultrasounds
• Subclinical fluid accumulation had PPV of 35%
& NPV of 90% for severe dengue.
• Gallbladder wall oedema-more pronounced
in severe dengue patients and often
preceded ascites/pleural effusion.
• Performed better than serial haematocrit and
albumin measurements
Michels, M et al. Plos NTD 2013
ESCMID eLibrary
by a
uthor
Viral Markers
• High viral replication associated with severe disease.
• Viraemias 10-100 times higher in DHF vs. DF.
Vaughn et al. JID 2000
ESCMID eLibrary
by a
uthor
Immunological markers
Immune marker Disease phase Comment
Elevated levels
IL-4, IL-6, IL-8, IL-10 Elevated febrile phase, peaking at defervescence
Elevated levels in DSS vs. DF, correlated with markers of disease severity. IL-10 correlated with thrombocytopenia
TNFa, sTNFR-75, sTNFR-80 Elevated in the febrile phase
Raised in severe dengue vs. mild disease. sTNFR predicted children who went on to develop shock
IFN-γ Early febrile phase, peaking defervescence
Severe disease associated with earlier peak IFN-γ levels .
C3a, C4a, C5a,Factor D Elevated in acute phase Elevated in DHF compared with DF
SC5b-9 terminal complement complex
Elevated in acute disease Higher levels were demonstrated in DF/DHF compared with OFI, and correlated with dengue severity
Reduced levels
RANTES/CCL5 Reduced levels during the acute phase
Reduced during acute phase and correlated with thrombocytopenia
IL1-b, IL-2, EGF Reduced levels during febrile phase
Lower levels of IL-2 and EGF in DSS compared with DF
VEGF, VEGFR2 Altered levels of VEGF and VEGFR2 around day of defervescence
There are mixed reports of VEGF levels
C3, factor H Reduced levels during acute dengue
Reduced levels were found in patients with DHF compared with those with DF and healthy controls
ESCMID eLibrary
by a
uthor
Data from this large cohort of patients, enrolled early with undifferentiated fever will be used to: 1) Develop a practical diagnostic algorithm and case definition for dengue and2) Identify simple clinical and laboratory parameters associated with progression
to a more severe disease course. ESCMID eLibrary
by a
uthor
Novel methods of predicting outcome :
Microvascular function
Rationale:
• Vascular system is the main target in dengue infections.
• Microcirculatory dysfunction plays major role in pathophysiology of multi-organ failure in severe infections.1
• Microvascular and endothelial dysfunction have prognostic value in other infections like sepsis and malaria.2
1.Vincent JL,et al Crit Care 2005. 2.De Backer D et al. Crit Care med 2013.
ESCMID eLibrary
by a
uthor
Pathogenesis of capillary leak in dengue
•Disruption of endothelial glyocalyx layer by the virus or NS1 Ag adhering to the endothelial layer.
•NS1 is a glycoprotein secreted from dengue infected cells, required for viral replication.
•NS1 can selectively binds to heparan sulfate in glycocalyx.
• Altering the microvascular permeability characteristics.
Simmons CP et al. N Engl J Med 2012;366:1423-1432.
ESCMID eLibrary
by a
uthor
Assessing microvascular function clinically
1. Videomicroscopy (Side stream dark field imaging)
Assessment of vessel density, flow, perfusion & glycocalyx depth.
2. Endothelium-dependent vasodilation. (Tests that stimulate increase in endothelium-derived NO)
3. Biochemical markers of endothelial activation:
Angiopoietin 2/ ICAM-1/VCAM-1/ & L- Arginine/ADMA
4. Glyocalyx shedding:
Syndecan/EndocanESCMID eLibrary
by a
uthor
Microcirculatory assessment:
Normal example Dengue late febrile phase
ESCMID eLibrary
by a
uthor
Proportion of perfused small vessels (top panel) and mean flow index (bottom panel) by day of illness in dengue patients with and without plasma leakage
Plasma leak grades0: No evidence of leak
1: moderate (15-20% ΔHCT and/or fluid accumulation)
2: Severe leakage (ΔHCT>20% and/or pleural effusion with Resp compromise, or shock.
P<0.01
P<0.01
ESCMID eLibrary
by a
uthor
Endothelial glycocalyx assessment
Perfused boundary region in dengue patients with different plasma leak
severities
ESCMID eLibrary
by a
uthor
Plasma syndecan levels in dengue patients with and without plasma leakage by illness phase
P<0.01ESCMID eLibrary
by a
uthor
Receiver operating characteristics for detecting plasma leakage illness days 4-6 using the Glycocalyx health score
AUC=0.70 (95% CI 0.52-0.88)
Glycocalyx health score –Combination of PBR and flow parameters
ESCMID eLibrary
by a
uthor
Vascular cell adhesion molecule-1 in dengue patients with and without plasma leakage over illness phases.
P<0.01ESCMID eLibrary
by a
uthor
Angiopoietin 2/1 ratio in dengue patients with and without plasma leakage over illness phases.
P<0.01ESCMID eLibrary
by a
uthor
Clinical endothelial function tests
• EndoPAT- Measures digital pulse volume amplitude changes
following an arterial occlusion test.
• Stimulates production & release of endothelial-derived NO, causing
vasodilation.
ESCMID eLibrary
by a
uthor
EndoPAT results
Example of PAT signal:
Occluded Arm
Control Arm
RHI=2.63
RHI=1.51
Dengue
Severe dengue
Reactive Hyperaemic Index(RHI) is the post occlusion- pre occlusion ratio
Normal RHI =>1.67
ESCMID eLibrary
by a
uthor
Endothelial function in first 3 days of illness by bleeding and plasma leakage
P=0.006P=0.78
n=48 n=22 n=62 n=12ESCMID eLibrary
by a
uthor
Novel ways of assessing intravascular volume
• The compensatory reserve Index (CRI) is a new physiological parameter
that tracks changes in central volume.
• Derived from feature analysis of pulse arterial waveform, using finger
pulse oximetry.
• Detects subtle volume changes during compensatory phase of shock.
• Arterial waveform data processed by an algorithm to calculate the CRI,
giving a value between 0 and 1.ESCMID eLibrary
by a
uthor
Point of Decompensation
Time
CR = Compensatory Reserve
DR = Decompensatory Reserve
1.0
0.8
0.6
0.4
0.2
0
Co
mp
en
sato
ry R
ese
rve
Ind
ex
Compensatory Reserve Index (CRI)
Progressive Volume Loss
ESCMID eLibrary
by a
uthor
Summary
• Many factors including differences in virus burden, virulence, host immune response, likely contribute to the final disease outcome
• Predicting outcome in dengue remains challenging and the search for more robust methods continues
• Although WHO warning signs are key for early recognition of progression to severe disease, the current evidence for any particular clinical or laboratory marker is weak.
• Potential algorithms incorporating clinical, viral, and/or endothelial biomarkers – may prove useful if validated in a larger cohort. ESCMID eLibrary
by a
uthor
Acknowledgements
OUCRU
Dengue group
Bridget Wills
Cameron Simmons
Heiman Wertheim
Lam Phung Khanh
Marcel Wolbers
HTD, HCMC
Nguyen Van Vinh Chau
Huynh Trung Trieu
Dong Thi Hoai Tam
Phan Tu Quí
Huynh Ngoc Thien Vuong
Hong Hanh Nguyen Ho
NHTD, Hanoi
Nguyen Van Kinh
Le Thi Lien
Tran Thi Toan
Menzies School of Health
Research, Darwin
Tsin Wen Yeo
Imperial College London
Gavin Screaton
Juthathip Mongkolsapaya
ESCMID eLibrary
by a
uthor